Back to search
Prurigo Nodularis
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Prurigo Nodularis trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Prurigo Nodularis trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
Evaluate the efficacy and safety of ICP-332 in participants with Prurigo Nodularis (PN)
The main aim of this study is to assess real-world effectiveness of nemolizumab in Prurigo nodularis (PN) as measured by investigator and patient reported outco…
This trial was designed to evaluate the efficacy and safety of SHR-1819 injection in patients with Prurigo Nodularis.
This is a Phase 3, multicenter, open-label, pharmacokinetics (PK)/safety study. The study consists of 3 periods: * Screening period: 2 to 4 weeks. * Treatment…
With the arrival of dupilumab as the first available targeted therapy for PN, there is an unmet need for real-world data and translational research on the worki…
Although it is well known that the clinical expression and course of chronic inflammatory skin diseases are highly variable, there are insufficient epidemiologi…
The purpose of this study is to evaluate the safety and tolerability of Ruxolitinib cream in participants with Prurigo Nodularis (PN).
The purpose of this study is to assess the efficacy and safety of barzolvolimab in adults with prurigo nodularis.